Opal Wealth Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-360
Closed -$21.3K 469
2026
Q1
$21.3K Buy
+360
New +$23.4K ﹤0.01% 590
2025
Q3
Sell
-518
Closed -$41.4K 446
2025
Q2
$41.4K Buy
518
+75
+17% +$6.27K 0.01% 408
2025
Q1
$38.1K Buy
+443
New +$36.3K 0.01% 393
2024
Q3
Sell
-377
Closed -$26K 891
2024
Q2
$26K Buy
+377
New +$25.5K 0.01% 445

Other funds holding PBH

Opal Wealth Advisors's PBH Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 360 shares — an estimated $21.3K sold.

Opal Wealth Advisors first reported a position in PBH in Q2 2024 and held it in 4 quarters. The position peaked at $41.4K in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Opal Wealth Advisors reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 360 Prestige Consumer Healthcare shares in Q2 2026, an estimated $21.3K.
  • Opal Wealth Advisors first reported a position in Prestige Consumer Healthcare in Q2 2024 and held it in 4 quarters.
  • Opal Wealth Advisors's Prestige Consumer Healthcare position peaked at $41.4K in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.